'Cet arrière-goût de violence': On violence against violence by Bojanić Petar

“…I will attempt to explain the connection between violence (someone's violence) and my own or Levinas's or the State's violence as a response to the initial violence (Violence against Violence) and finally the violence which remains in the mouth, throat, aftertaste [gout] or in disgust [degout]. 'Cet arrière-goût de violence' or 'un quelconque arrière-goût de degout' [a sort of aftertaste of disgust].…”
Get full text

Advances in the management of gout: Critical appraisal of febuxostat in the control of hyperuricemia by Lada Beara-Lasic, Michael H Pillinger, David S Goldfarb

“…However, epidemiologic studies indicate that the quality of gout management is suboptimal owing to both patient and physician issues. …”
Get full text

GOUT AND HYPERURICEMIA AS ADDITIONAL FACTORS OF DETERIORATION OF CARDIAC AND RENAL PATHOLOGIES by Snigurska I. O., Bozhko V. V., Miloslavsky D. K., Starchenko T. G.

Subjects: “…hyperuricemia,gout,cardiovascular diseases,drugs that affect uric acid metabolism.…”
Get full text

Analysis of Metabolites in Gout: A Systematic Review and Meta-Analysis by Yuanyuan Li, Xu Han, Jinlin Tong, Yuhe Wang, Xin Liu, Zeqi Liao, Miao Jiang, Hongyan Zhao

Subjects: “…gout…”
Get full text

Joint Application of Multiple Inflammatory Cytokines in Diagnosis of Gout Flare by Yu H, Xue W, Yu H, Gu H, Qin L, Peng A

Subjects: “…acute gout…”
Get full text

Clinical significance of adipokine profile (leptin and adiponectin) in patients with gout by I.V. Orlova, M.A. Stanislavchuk

Subjects: “…gout…”
Get full text

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis by Maksim Sergeyevich Eliseyev, I S Denisov, V G Barskova

“…The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. …”
Get full text

Glomerular filtration rate in patients with gout and factors influencing the rate by F M Kudaeva, A V Gordeev, V G Barskova, F M Kudayeva, A V Gordeyev, V G Barskova

Get full text

UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS by M. S. Eliseev

Subjects: “…gout…”
Get full text

MAGNESIUM OROTATE IN COMPLEX THERAPY OF METABOLIC DISORDERS IN PATIENTS WITH GOUT by S. I. Smiian, M. V. Franchuk, L. V. Balaban

“…In 25–90 % patients with gout we detect metabolic syndrome (MS), and on the contrary – in patients with MS significantly increases the risk of gout and hyperuricemia (HU). …”
Get full text

CLINICAL FEATURES OF GOUT IN WOMEN: THE RESULTS OF A COMPARATIVE STUDY by M. S. Eliseev, N. A. Chikalenkova, V. G. Barskova

Subjects: “…gout…”
Get full text

OPIOID IN THE PAIN MANAGEMENT OF ACUTE GOUT ARTHRITIS: FRIEND OR FOE? by Mega Nilam Sari, Florence Pribadi, Eva M. Anigomang, Gede T.W. Suara, Karmila A. Wardani, Kharisma A. Perdana, Lidya Anin, Yasmine P. Fadhilah, Kevin Luke

Subjects: Get full text

Rare Presentation of Disseminated Gout Nodulosis and Chronic Inflammatory Arthritis by Faria Sami, Shahzad Ahmed Sami, Shilpa Arora

“…Background. Gout is an inflammatory arthritis caused by monosodium urate (MSU) deposition. …”
Get full text

Increased platelet reactivity as measured by plasma glycoprotein VI in gout by Richard Conway, Claire-Louise Murphy, Anne Madigan, Patricia Kavanagh, Liz Geraghty, Niamh Redmond, Laura Helbert, John J. Carey, Eimear Dunne, Dermot Kenny, Geraldine M. McCarthy

Subjects: Get full text

An evaluation of gout visits in the United States for the years 2007 to 2011 by Kristen E. Castro, Kaitlyn D. Corey, Diana L. Raymond, Michael R. Jiroutek, Melissa A. Holland

Subjects: “…Gout…”
Get full text

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update by Robert Eckenstaler, Ralf A. Benndorf

Subjects: “…gout…”
Get full text

Experience with canakinumab in a patient with gout and IgA nephropathy by E. V. Ilyinykh, M. S. Eliseev

“…The paper discusses the results of clinically using the interleukin-1_ inhibitor canakinumab in a patient with chronic tophaceous gout, IgA nephropathy, and chronic kidney disease with resistance to traditional anti-inflammatory drugs (colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and high-dose glucocorticoids) and a history of failed urate-lowering therapy. …”
Get full text

A case report of pathologic fracture of patella secondary to gout by Chi Ma, Gang Luo, Cheng Chen, Jun Zhao

Subjects: “…Gout…”
Get full text

Oh my gout : know your facts before it attacks by Kee, Benedict Liwen, Phua, Shi Ting, Syahirah Afifah Abu Bakar, Nur Hafizah Akbar Ali

“…Oh My Gout! (OMG) is the first gout awareness communications campaign in Singapore, a country with an increasing number of gout sufferers in recent years. …”
Get full text

Involvement of oxidative stress in patients of gout and antioxidant effect of allopurinol by Chetan R. Acharya, Abhinav K. Sharma, ND Kantharia

“…Conclusion: From this study, it can be suggested that hyperuricemia causes oxidative stress in patients with gout. Besides the main benefit of lowering serum uric acid level, allopurinol also decreases oxidative stress in patients with gout.…”
Get full text